Anthony Rothschild, MD, a professor at the Irving S. and Betty Brudnick Endowed Chair of Psychiatry, University of Massachusetts Medical School, says that many primary care physicians feel more comfortable prescribing newer anti-depressant drugs with fewer side effects.
Anthony Rothschild, MD, a professor at the Irving S. and Betty Brudnick Endowed Chair of Psychiatry, University of Massachusetts Medical School, says that many primary care physicians feel more comfortable prescribing newer anti-depressant drugs with fewer side effects.
He adds that patients who are diagnosed with depression for the 1st time are often done so by their primary care physician. This is because he or she may not have believed they were suffering from depression and would not have previously considered contacting a psychiatrist. Physicians are in a “unique position” to diagnose patients with depression and to prescribe an anti-depressant drug regimen.
However, Dr Rothschild explains that there are certain types of depression that should not be handled by primary care physicians alone. He recommends that primary care physicians refer patients who suffer from conditions such as psychotic depression or bipolar disorder to a psychiatrist, as they can be more complicated.
“It’s not unusual for me to see patients with depression who may have had 1 trial of an anti-depressant from their primary care physician,” Dr Rothschild says. “If it works out, I don’t ever see them. But, if it doesn’t work out then and it becomes a little more complicated, then the primary care doctor will refer the patient to a psychiatrist.”
Dr Rothschild also serves as director at the UMass Medical Depression Center and Center for Psychopharmacologic Research and Treatment, and as a program director at the Mood Disorders Comprehensive Consultation Clinic at UMass Memorial Medical Center.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More